The effect of glucagon like peptide-1 receptor agonist on behavioral despair and anxiety-like behavior in ovariectomized rats: modulation of BDNF/CREB, Nrf2 and lipocalin 2
The work done in labs today could pave the way for approved medical treatments tomorrow, but we are not there yet
Once-weekly subcutaneous retatrutide administration heightened the risk of gastrointestinal and hypersensitivity incidents, typically non-severe
Sources Ozempic (semaglutide) Ozempic Weight-Loss Prescription Medication | Wegovy (semaglutide) Injection 2.4 mg Ozempic 0.25 mg solution for injection in pre-filled pen Summary of Product Characteristics (SmPC) (emc) Wegovy 0.25 mg, FlexTouch solution for injection in pre-filled pen Summary of Product Characteristics (SmPC) (emc) NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current
People who take these medications lose weight as a side effect
Finally, recent findings additionally suggest that the GLP1r also modulates systemic metabolism by limiting the bioavailability of intestinal GLP-1(He et al., 2019)
